YD Bio Limited Ordinary Shares logo

YD Bio Limited Ordinary Shares

YDES | NASDAQ
Chart Builder DCF Calculator
$2.64
+$0.01 (+0.38%)
Sep 22, 2026, 12:22 PM ET · Market open
Fiscal Quarter
Period Ending
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Net Income
-2.21M -3.37M 417.79K 2.19M 17.1M -22.02M 692.04K
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
89.08K -134.83K 15.64K 226.47K -48.85K 423.08K -197.32K
Other Non-Cash Items
1.83M 3.01M -799.08K -2.44M -17.65M 20.96M -1.18M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
89.08K -134.83K 15.64K 226.47K -48.85K 423.08K -197.32K
Operating Cash Flow
-298.19K -490.41K -365.65K -21.57K -592.52K -629.74K -688.42K
Capital Expenditures
n/a -3 n/a n/a -3 n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-26.9K -69.37K -93.84K -62.56K -81.15K -121.72K -121.72K
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
584.39K 7.35M 262.23K n/a 3.14M n/a n/a
Investing Cash Flow
557.48K 7.28M 168.39K -62.56K 3.06M -121.72K -121.73K
Debt Repayment
331K 458.51K 298.94K 44.16K 650.15K 751.72K 632.69K
Common Stock Repurchased
-584.39K -7.35M n/a n/a -3.08M n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow
-253.39K -6.89M 298.94K 44.16K -2.43M 751.72K 632.69K
Net Cash Flow
5.91K -101.27K 101.67K -39.97K 35.48K 259 -177.45K
Free Cash Flow
-298.19K -490.41K -365.65K -21.57K -592.52K -629.74K -688.42K
Adj. Free Cash Flow
-298.19K -490.41K -365.65K -21.57K -592.52K -629.74K -688.42K
Maintenance CapEx
n/a -3 n/a n/a -3 n/a n/a
Growth CapEx
n/a n/a n/a n/a n/a n/a n/a
Owner Earnings
-298.19K -490.41K -365.65K -21.57K -592.52K -629.74K -688.42K

© 2026 bestshares.com. All rights reserved.